Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND AND PURPOSE: VBM is increasingly used in the study of neurodegeneration, and recently there has been interest in its potential as a biomarker. However, although it is largely "automated," VBM is rarely implemented consistently across studies, and changing user-specified options can alter the results in a way similar to the very biologic differences under investigation. MATERIALS AND METHODS: This work uses data from patients with HD to demonstrate the effects of several user-specified VBM parameters and analyses: type and level of statistical correction, modulation, smoothing kernel size, adjustment for brain size, subgroup analysis, and software version. RESULTS: The results demonstrate that changing these options can alter results in a way similar to the biologic differences under investigation. CONCLUSIONS: If VBM is to be useful clinically or considered for use as a biomarker, there is a need for greater recognition of these issues and more uniformity in its application for the method to be both reproducible and valid.

Original publication

DOI

10.3174/ajnr.A1939

Type

Journal article

Journal

AJNR Am J Neuroradiol

Publication Date

04/2010

Volume

31

Pages

711 - 719

Keywords

Adult, Biomarkers, Brain, Female, Genetic Predisposition to Disease, Heterozygote Detection, Humans, Huntington Disease, Image Processing, Computer-Assisted, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Organ Size, Reference Values, Sensitivity and Specificity, Software, Trinucleotide Repeats